1.
Leuk Res Rep
; 18: 100342, 2022.
Article
in English
| MEDLINE | ID: covidwho-2181342
ABSTRACT
Myeloma patients are at an increased risk of severe forms of Covid-19. We examined response to mRNA vaccine between myeloma patients (n.127) and healthy volunteers (n.50). Anti-spike IgG antibody were detected in 76.9% of evaluable patients. 23.1% of MM patients failed to respond at two doses of COVID-19 mRNA vaccine. Univariate analyses identified three independent adverse predictive factors of absence of immunological response to COVID-19 vaccine: extreme plasmacytosis (p < 0.001), B2M (p 0.006), and haemoglobin (p 0.008). Multivariate analysis confirmed the extreme plasmacytosis and haemoglobin value as statistically significant variables.
2.
Leuk Res Rep
; 18: 100347, 2022.
Article
in English
| MEDLINE | ID: covidwho-2007932
ABSTRACT
[This corrects the article DOI: 10.1016/j.lrr.2022.100342.].